Trials / Recruiting
RecruitingNCT05539677
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
Analysis of the Immunogenetic Profile of Patients With Aggressive Course of Malignant Neoplastic Process Resistant to the Standard Treatment Approaches: a Translational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- N.N. Petrov National Medical Research Center of Oncology · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies
Conditions
- Malignant Solid Tumors
- Primary Brain Tumor
- Melanoma
- Soft Tissue Sarcoma
- Colorectal Cancer
- Kidney Cancer
- Prostate Cancer
Timeline
- Start date
- 1998-09-01
- Primary completion
- 2030-12-01
- Completion
- 2030-12-01
- First posted
- 2022-09-14
- Last updated
- 2024-05-06
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT05539677. Inclusion in this directory is not an endorsement.